These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 19852961)

  • 21. Optical molecular imaging approaches in colorectal cancer.
    Mahmood U
    Gastroenterology; 2010 Feb; 138(2):419-22. PubMed ID: 20026448
    [No Abstract]   [Full Text] [Related]  

  • 22. Meta-analysis of confocal laser endomicroscopy for the detection of colorectal neoplasia.
    Dong YY; Li YQ; Yu YB; Liu J; Li M; Luan XR
    Colorectal Dis; 2013 Sep; 15(9):e488-95. PubMed ID: 23810105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Fluorescence Endoscopy Targeting Vascular Endothelial Growth Factor A for Improved Colorectal Polyp Detection.
    Tjalma JJ; Garcia-Allende PB; Hartmans E; Terwisscha van Scheltinga AG; Boersma-van Ek W; Glatz J; Koch M; van Herwaarden YJ; Bisseling TM; Nagtegaal ID; Timmer-Bosscha H; Koornstra JJ; Karrenbeld A; Kleibeuker JH; van Dam GM; Ntziachristos V; Nagengast WB
    J Nucl Med; 2016 Mar; 57(3):480-5. PubMed ID: 26678613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Near-Infrared Confocal Laser Endomicroscopy Detects Colorectal Cancer via an Integrin αvβ 3 Optical Probe.
    Schulz P; Dierkes C; Wiedenmann B; Grötzinger C
    Mol Imaging Biol; 2015 Aug; 17(4):450-60. PubMed ID: 25622811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prioritization of EGFR/IGF-IR/VEGFR2 combination targeted therapies utilizing cancer models.
    Tonra JR; Corcoran E; Deevi DS; Steiner P; Kearney J; Li H; Ludwig DL; Zhu Z; Witte L; Surguladze D; Hicklin DJ
    Anticancer Res; 2009 Jun; 29(6):1999-2007. PubMed ID: 19528458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-CD3 x anti-epidermal growth factor receptor (EGFR) bispecific antibody redirects T-cell cytolytic activity to EGFR-positive cancers in vitro and in an animal model.
    Reusch U; Sundaram M; Davol PA; Olson SD; Davis JB; Demel K; Nissim J; Rathore R; Liu PY; Lum LG
    Clin Cancer Res; 2006 Jan; 12(1):183-90. PubMed ID: 16397041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic antitumor effects of combined epidermal growth factor receptor and vascular endothelial growth factor receptor-2 targeted therapy.
    Tonra JR; Deevi DS; Corcoran E; Li H; Wang S; Carrick FE; Hicklin DJ
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2197-207. PubMed ID: 16609035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vivo confocal real-time mini-microscopy in animal models of human inflammatory and neoplastic diseases.
    Goetz M; Fottner C; Schirrmacher E; Delaney P; Gregor S; Schneider C; Strand D; Kanzler S; Memadathil B; Weyand E; Holtmann M; Schirrmacher R; Weber MM; Anlauf M; Klöppel G; Vieth M; Galle PR; Bartenstein P; Neurath MF; Kiesslich R
    Endoscopy; 2007 Apr; 39(4):350-6. PubMed ID: 17427071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR.
    Luwor RB; Johns TG; Murone C; Huang HJ; Cavenee WK; Ritter G; Old LJ; Burgess AW; Scott AM
    Cancer Res; 2001 Jul; 61(14):5355-61. PubMed ID: 11454674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges in the use of epidermal growth factor receptor inhibitors in colorectal cancer.
    Van Cutsem E
    Oncologist; 2006 Oct; 11(9):1010-7. PubMed ID: 17030643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
    Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
    Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa.
    Bhargava R; Chen B; Klimstra DS; Saltz LB; Hedvat C; Tang LH; Gerald W; Teruya-Feldstein J; Paty PB; Qin J; Shia J
    Cancer; 2006 Apr; 106(8):1857-62. PubMed ID: 16532444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and evaluation of a cetuximab-based imaging probe to target EGFR and EGFRvIII.
    Aerts HJ; Dubois L; Hackeng TM; Straathof R; Chiu RK; Lieuwes NG; Jutten B; Weppler SA; Lammering G; Wouters BG; Lambin P
    Radiother Oncol; 2007 Jun; 83(3):326-32. PubMed ID: 17531336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer.
    Wong SF
    Clin Ther; 2005 Jun; 27(6):684-94. PubMed ID: 16117976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of epidermal growth factor receptor (EGFR) expression in primary colorectal carcinomas and their related metastases on tissue sections and tissue microarray.
    Bibeau F; Boissière-Michot F; Sabourin JC; Gourgou-Bourgade S; Radal M; Penault-Llorca F; Rochaix P; Arnould L; Bralet MP; Azria D; Ychou M
    Virchows Arch; 2006 Sep; 449(3):281-7. PubMed ID: 16865406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular testing in colorectal cancer: diagnosis of Lynch syndrome and personalized cancer medicine.
    Shi C; Washington K
    Am J Clin Pathol; 2012 Jun; 137(6):847-59. PubMed ID: 22586043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopic molecular imaging of early gastric cancer using fluorescently labeled human H-ferritin nanoparticle.
    Du Y; Fan K; Zhang H; Li L; Wang P; He J; Ding S; Yan X; Tian J
    Nanomedicine; 2018 Oct; 14(7):2259-2270. PubMed ID: 30056091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Confocal laser endomicroscopy for the morphometric evaluation of microvessels in human colorectal cancer using targeted anti-CD31 antibodies.
    Cârţână T; Săftoiu A; Gruionu LG; Gheonea DI; Pirici D; Georgescu CV; Ciocâlteu A; Gruionu G
    PLoS One; 2012; 7(12):e52815. PubMed ID: 23285192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular determination of epidermal growth factor receptor in normal and neoplastic colorectal mucosa.
    Piazzi G; Paterini P; Ceccarelli C; Pantaleo MA; Biasco G
    Br J Cancer; 2006 Dec; 95(11):1525-8. PubMed ID: 17088913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.